Upon MIF/CD74 binding, CD44 is recruited to the receptor complex to initiate Src-family kinase activation, CD44 alternative exon splicing, and expression of tumor-associated isoforms such as CD44v3–v6, which are implicated in enhancing cellular migration, adhesion, and invasion. The gene discussed is CD44; the disease is neoplasm.